UBS Group AG Acquires 166,022 Shares of Genpact Limited (NYSE:G)

UBS Group AG boosted its holdings in Genpact Limited (NYSE:G – Get Rating) by 1,516.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 176,970 shares of the business services provider’s stock after buying an additional 166,022 shares during the period. UBS Group AG owned approximately 0.10% of Genpact worth $8,197,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of Genpact by 110.2% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 11,587 shares of the business services provider’s stock valued at $507,000 after purchasing an additional 6,075 shares during the period. AXA S.A. bought a new stake in shares of Genpact during the third quarter valued at approximately $1,537,000. Affiance Financial LLC bought a new stake in shares of Genpact during the fourth quarter valued at approximately $74,000. LMR Partners LLP bought a new stake in shares of Genpact during the third quarter valued at approximately $900,000. Finally, Point72 Hong Kong Ltd bought a new stake in shares of Genpact during the third quarter valued at approximately $183,000. 95.17% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently commented on G shares. Citigroup decreased their price target on Genpact from $54.00 to $46.00 in a research note on Thursday, May 11th. BMO Capital Markets boosted their price target on Genpact from $51.00 to $53.00 and gave the company a “market perform” rating in a research note on Wednesday, February 8th. StockNews.com started coverage on Genpact in a research note on Thursday, May 18th. They issued a “buy” rating on the stock. Robert W. Baird decreased their price target on Genpact from $54.00 to $48.00 in a research note on Thursday, May 11th. Finally, Jefferies Financial Group decreased their price target on Genpact from $47.00 to $41.00 in a research note on Monday, May 15th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Genpact currently has a consensus rating of “Moderate Buy” and an average price target of $49.00.

Genpact Price Performance

Genpact stock opened at $37.82 on Thursday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.84 and a current ratio of 1.84. The firm has a market cap of $6.96 billion, a P/E ratio of 19.49, a P/E/G ratio of 1.74 and a beta of 1.20. The business’s fifty day moving average is $42.81 and its two-hundred day moving average is $45.03. Genpact Limited has a 52 week low of $35.75 and a 52 week high of $48.85.

Genpact (NYSE:G – Get Rating) last posted its quarterly earnings data on Wednesday, May 10th. The business services provider reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.55 by $0.05. The company had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.10 billion. Genpact had a return on equity of 25.74% and a net margin of 8.27%. Equities research analysts forecast that Genpact Limited will post 2.49 earnings per share for the current fiscal year.

Genpact Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 26th. Stockholders of record on Friday, June 9th will be paid a dividend of $0.1375 per share. This represents a $0.55 annualized dividend and a dividend yield of 1.45%. The ex-dividend date is Thursday, June 8th. Genpact’s dividend payout ratio (DPR) is presently 28.35%.

Insider Activity

In other news, SVP Balkrishan Kalra sold 20,000 shares of the company’s stock in a transaction on Monday, March 6th. The stock was sold at an average price of $47.33, for a total transaction of $946,600.00. Following the transaction, the senior vice president now owns 155,328 shares of the company’s stock, valued at $7,351,674.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, SVP Balkrishan Kalra sold 20,000 shares of the company’s stock in a transaction dated Monday, March 6th. The stock was sold at an average price of $47.33, for a total value of $946,600.00. Following the completion of the sale, the senior vice president now owns 155,328 shares in the company, valued at $7,351,674.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Heather White sold 12,500 shares of the company’s stock in a transaction dated Friday, May 5th. The shares were sold at an average price of $40.72, for a total value of $509,000.00. Following the completion of the sale, the senior vice president now owns 40,845 shares of the company’s stock, valued at approximately $1,663,208.40. The disclosure for this sale can be found here. Insiders have sold 315,000 shares of company stock valued at $13,511,225 over the last 90 days. 2.62% of the stock is owned by company insiders.

Genpact Company Profile

(Get Rating)

Genpact Ltd. engages in the business process management, outsourcing, shared services and information outsourcing. The company operates through the following segments: Banking, Capital Markets and Insurance (BCMI), Consumer Goods, Retail, Life Sciences, and Healthcare (CGRLH) and High Tech, Manufacturing, and Services (HMS).